1Calnek DS, Mazzella L, Roser S, et al. Peroxisome proliferator-activated receptor ligands increase of nitric oxide from endothelial cells[J]. Arterioscler Thromb Vasc Biol, 2003,23(1) :52.
2Wang TD, Chen WJ, Lin JW, et al. Effects of rosiglitazone on endothelial function, C-reactive protein, and components of the metabolic syndrome in nondiabetie patients with the metabolic syndrome[J]. Am J Cardiol, 2004, 93 (3) :362.
3Kim SK,Hur KY,Kim HJ,et al. The increase in abdominal subcutaneous fat depot is an independent factor to determine the glycemic control after rosiglitazone treatment[J]. Eur J Endocrinol,2007,157(2) :167.
4Riedel AA, Heien H, Wogen J, et al. Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedi one monotherapy[J]. Pharmacotherapy, 2007, 27 (8) : 1102.
5Bolten CW ,Payne MA, McDonald WG, et al. Thiazolidinediones inhibit the progression of established hypertension in the Dahl salt-sensitive rat[J]. Diabetes Vasc Dis Res, 2007,4(2) :117.
7Galli A, Ceni E, Grabb DW, et al. Antidiabetic thiazolidin ediones inhibit invasiveness of pancreatic cancer cells via PPARgamma independent mechanisms[J]. Gut, 2004, 53(11):1688.
8Shimada T, Kojima K, Yoshiura K, et al. Characteristics of the peroxisome activated receptor gamma (PPAR gamma) ligand induced apoptosis in colon cancer cells[J]. Gut,2002,50(5):658.
9Ahmed W, Ziouzenkova O, Brown J, et al. PPARs and their metabolic modulation: new mechanisms for transcriptional regulation[J]. J Intern Med, 2007, 262 (2) : 184.
10Mody M, Dharker N, Bloomston M, et al. Rosiglitazone sensitizes MDA-MB-231 breast cancer cells to antitumour effects of tumour necrosis factor- { alpha }, CH11 and CYC202[J]. Endocr Relat Cancer,2007,14(2):305.
6Kawachi H, Koike H, Kurihara H, et al. Cloning of rat nephrin:expression in developing glomeruli and in proteinuric states[J]. Kidney Int, 2000,57 (5) : 1949.
7Topham PS, Kawachi H, Haydar SA, et al. Nephritogenie mAb 5-1-6 is directed at the extracellular domain of rat nephrin[J].J Ciin Invest,1999,104(11) :1559.
8Wickelgren I. First components found for new kidney filter[J]. Science, 1999,286 (5438) : 225.
9Luimula P, Ahola H, Wang SX, et al. Nephrin in experimental glomerular disease[J]. Kid Inter, 2000, 58 (4) : 1461.
10Furness PN, Hall L, Shaw JA, et al. Glomerular expression of nephrin is decreased in acquired human nephrotic syndrome[J]. Nephrol Dial Transplant, 1999, 14 ( 5 ) : 1234.
